Antineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyChemoradiotherapyRadiotherapy DosageRadiation InjuriesRadiotherapy, ConformalRadiotherapy, Intensity-ModulatedChemotherapy, AdjuvantCisplatinDose FractionationDose-Response Relationship, RadiationRadiotherapyEsophagitisRadiation PneumonitisTreatment OutcomeRadiation DosageNeoplasm StagingRadiation, IonizingCarboplatinAntineoplastic AgentsMucositisLung NeoplasmsDisease-Free SurvivalProton TherapyCarcinoma, Non-Small-Cell LungNasopharyngeal NeoplasmsFluorouracilSurvival AnalysisCarcinoma, Squamous CellRadiotherapy, AdjuvantRadiotherapy, High-EnergySurvival RateThoracic NeoplasmsPaclitaxelOrgans at RiskHead and Neck NeoplasmsNeoadjuvant TherapyEtoposideNeoplasm Recurrence, LocalRadiation ToleranceDrug Administration ScheduleRadiationAnus NeoplasmsPrognosisFollow-Up StudiesBrachytherapyRadiation ProtectionUterine Cervical NeoplasmsEsophageal NeoplasmsKaplan-Meier EstimateRadiation MonitoringRetrospective StudiesRadiotherapy Planning, Computer-AssistedDoxorubicinCyclophosphamideAdenocarcinomaNeoplasm MetastasisBreast NeoplasmsTreatment FailureCarcinomaRadiation OncologyCarcinoma, Small CellCosmic RadiationRadiation Injuries, ExperimentalMethotrexateNeoplasmsTime FactorsInduction ChemotherapyVinblastineNeoplasms, Radiation-InducedGamma RaysTaxoidsRemission InductionDeoxycytidineBackground RadiationAntimetabolites, AntineoplasticBleomycinRadiation-Sensitizing AgentsDrug Resistance, NeoplasmBrain NeoplasmsIfosfamideRadiometryOrganoplatinum CompoundsAntineoplastic Agents, AlkylatingUltraviolet RaysSalvage TherapyProspective StudiesRadiation-Protective AgentsRadiation EffectsDacarbazineHodgkin DiseaseAnthracyclinesCytarabineAntineoplastic Agents, PhytogenicCell Line, TumorLymphoma, Non-HodgkinOvarian NeoplasmsNeutropeniaChemotherapy, Cancer, Regional PerfusionDose-Response Relationship, Drug